Inhibition of TNF-α expression in a murine model resulted in significantly reduced hepatic steatosis and fibrosis, together with decreased expression of MCP-1, TGF-β, Col1a1 and metallopeptidase inhibitor 1 [65]. The gene discussed is TGFB1; the disease is Hepatic steatosis.